Prmt5 Dimethylation
Prmt5 Dimethylation - Related Videos
02:35
Long-Term Cryopreservation of Cyanobacterial Strains Using Glycerol or Dimethyl Sulfoxide
0 Views •
2025
Source: Lea-Smith, D. J., et al. Generation of Marked and Markerless Mutants in Model Cyanobacterial Species. J. Vis. Exp. (2016)This video demonstrates the cryopreservation of cyanobacterial strains by combining concentrated cell suspensions with glycerol or DMSO and storing them at low temperatures, enabling long-term maintenance of viable cultures for photosynthesis and genetic studies.
13:59
Methods to Identify the NMR Resonances of the 13C-Dimethyl N-terminal Amine on Reductively Methylated Proteins
0 Views •
Cited by 4 •
2013
Two methods for assigning the α- and ε-dimethylamine nuclear magnetic resonance signals of a reductively 13C-methylated N-terminal lysine are described. One method utilizes the pH-induced selectivity of the reductive methylation reaction, and the other uses aminopeptidase to selectively remove the N-terminal lysine.
11:53
Quantitative Proteomics Using Reductive Dimethylation for Stable Isotope Labeling
0 Views •
Cited by 38 •
2014
Stable isotope labeling of peptides by reductive dimethylation (ReDi labeling) is a rapid, inexpensive strategy for accurate mass spectrometry-based quantitative proteomics. Here we demonstrate a robust method for preparation and analysis of protein mixtures using the ReDi approach that can be applied to nearly any sample type.
10:34
Probing RNA Structure with Dimethyl Sulfate Mutational Profiling with Sequencing In Vitro and in Cells
0 Views •
Cited by 4 •
2022
The protocol provides instruction for modifying RNA with dimethyl sulfate for mutational profiling experiments. It includes in vitro and in vivo probing with two alternative library preparation methods.
10:09
Isolation and Cultivation of Neural Progenitors Followed by Chromatin-Immunoprecipitation of Histone 3 Lysine 79 Dimethylation Mark
0 Views •
Cited by 2 •
2018
We present an effective and reproducible method to isolate and culture neural progenitor cells from embryonic and postnatal brain tissue for chromatin immunoprecipitation (ChIP) of histone 3 lysine 79 dimethylation (H3K79me2) - a histone mark located within the globular domain of histone 3.
FAQs
S-adenosylmethionine supplies the methyl groups transferred during the reaction. PRMT5 uses this donor to modify arginine residues, producing symmetric dimethylarginine on selected protein substrates. Because methyl-donor availability is directly connected to the modification reaction, this chemical input is an important part of understanding how PRMT5 activity can influence downstream protein behavior and gene regulation.
MEP50 commonly partners with PRMT5 during substrate modification. This partnership is significant because PRMT5 does not act only as an isolated enzyme in the cellular context described here. Examining PRMT5 together with MEP50 can therefore help researchers interpret how the modification is generated on histones and nonhistone proteins involved in RNA processing and cell-cycle control.
The modification reaches two functionally different protein groups. On histones, it can influence chromatin state and transcription, whereas modification of nonhistone proteins can affect processes such as RNA processing and cell-cycle control. This broad substrate range helps explain why altered PRMT5 activity may produce coordinated changes in gene regulation, signaling, and tumor-cell behavior rather than a single isolated effect.
Abnormal activity can reshape chromatin state, transcription, and signaling pathways that support tumor-cell survival and proliferation. The relevant outcome depends on which histone or nonhistone substrates are affected and how their functions change after modification. Studying these connections gives cancer researchers a framework for linking PRMT5 dysregulation with tumor biology and for identifying consequences that may be therapeutically relevant.
Researchers can investigate the modification by measuring its presence and by examining the effects of inhibiting PRMT5. These complementary approaches connect molecular activity with broader outcomes in tumor biology. Measurement indicates whether the modification is present or altered, while inhibition helps test whether PRMT5-dependent activity contributes to cancer-associated processes such as survival, proliferation, transcription, or signaling.
Measurement can reveal changes in PRMT5-associated dimethylation on histones or nonhistone proteins and help relate those changes to altered cellular regulation. In cancer studies, this information supports analysis of chromatin state, transcription, RNA processing, and cell-cycle control. It can also help researchers evaluate whether PRMT5 activity is associated with tumor-cell survival or proliferation in a particular experimental system.
Inhibiting PRMT5 allows researchers to test whether cancer-related phenotypes depend on its modification activity. Comparing cells or experimental systems with reduced PRMT5 function can clarify effects on tumor-cell survival and proliferation while connecting those outcomes to disrupted gene regulation or signaling. This makes inhibition a research strategy for evaluating PRMT5 as a potential targeted-therapy focus, not merely a way to measure the modification.